Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biological Signature for the Early Differential Diagnosis of Psychosis: Unveiling the Differences Between Mood Disorders and Schizophrenia With Multimodal Machine Learning Techniques

NCT06515522 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06515522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06515522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biological Signature for the Early Differential Diagnosis of Psychosis: Unveiling the Differences Between Mood Disorders and Schizophrenia With Multimodal Machine Learning Techniques
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2024
Completion date
August 31, 2026
Enrollment
1,850 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, major depressive disorder, schizophrenia